OpenAlex
PricingAboutJobs
Log inGet started
Work

Efficacy, safety, and tolerability of lacosamide monotherapy versus controlled-release carbamazepine in patients with newly diagnosed epilepsy: a phase 3, randomised, double-blind, non-inferiority trial

HTML

Year: 2016
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: The Lancet Neurology
DOI: 10.1016/s1474-4422(16)30292-7
Authors: Michel Baulac, Felix Rosenow, Manuel Toledo, Kiyohito Terada, Ting Li, Marc De Backer, Konrad J Werhahn, Melissa Brock
Institutions: Assistance Publique – Hôpitaux de Paris, Pitié-Salpêtrière Hospital, Institut du Cerveau, Goethe University Frankfurt, Vall d'Hebron Hospital Universitari, National Epilepsy Center, UCB Pharma (Belgium), UCB Pharma (Germany)
Language: English

Topic: Epilepsy research and treatment
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Keywords: lacosamide, carbamazepine, newly diagnosed epilepsy, seizure freedom, non-inferiority, drug safety and tolerability, adverse events, drug interactions, dose titration, controlled-release formulation
SDG: Good health and well-being

Open Access status: closed

Funders: Deutsche Forschungsgemeinschaft, UCB Pharma
OpenAlex ID: W2556184649
FWCI: 9.981
Cites: 34
Cited by: 173
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms